12-53073317-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_032840.3(SPRYD3):c.662G>A(p.Gly221Asp) variant causes a missense change. The variant allele was found at a frequency of 0.000000763 in 1,311,286 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_032840.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SPRYD3 | NM_032840.3 | c.662G>A | p.Gly221Asp | missense_variant | Exon 6 of 11 | ENST00000301463.9 | NP_116229.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 29
GnomAD3 exomes AF: 0.00000444 AC: 1AN: 225180Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 120918
GnomAD4 exome AF: 7.63e-7 AC: 1AN: 1311286Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 648620
GnomAD4 genome Cov.: 29
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.662G>A (p.G221D) alteration is located in exon 6 (coding exon 6) of the SPRYD3 gene. This alteration results from a G to A substitution at nucleotide position 662, causing the glycine (G) at amino acid position 221 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at